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Background
As individuals with HIV infection live longer due to
highly active antiretroviral therapy (HAART), co-morbid
conditions and infections, including liver cancers and
viral hepatitis, warrant increased attention and action.
Materials and methods
The multisite ASD Project followed 29,491 HIV-infected
individuals receiving medical care in 11 U.S. metropoli-
tan areas for an average of 2.4 years and a total of
69,487 person-years. ASD collected data on the presen-
tation, treatment, and outcomes related to HIV infec-
tion, including viral hepatitis screening and liver-specific
complications including hepatic neoplasms. Data were
restricted to the HAART era, 1998-2004.
Results
There were 25 participants with liver malignancies in
the ASD cohort corresponding to a rate of 8.5 cancers/
10,000 people living with HIV. Twenty two (88%) parti-
cipants died and the remaining 3 were lost to followup.
Fifteen (60%) of the 25 had hepatocellular carcinoma;
6 had metastatic adenocarcinoma, 1 each had lym-
phoma, hepatoblastoma, sarcoma, and poorly differen-
tiated carcinoma. Thirteen of 25 (52%) individuals with
liver malignancies were diagnosed with hepatitis C virus
(HCV) and 10 (40%) with chronic hepatitis B virus
(HBV) infection (including 2 participants with HBV and
HCV co-infection). This corresponds to a relative risk of
liver cancer among HCV and HBV infected individuals
of 12.8 (95% confidence interval [CI] = 4.1-40.2) and
26.8 (95% CI = 8.1-88.9), respectively (relative to those
without HBV or HCV diagnoses). The risk of malig-
nancy in HIV-infected individuals with both HBV and
HCV co-infection, relative to those with neither co-
infection, was 16.8 (95% CI = 3.1-91.8). Four individuals
did not undergo HBV or HCV screening, and their viral
hepatitis serostatus remained undefined. Twelve percent
of liver cancer patients also had a diagnosis of cirrhosis,
relative to a 1 percent prevalence of cirrhosis overall
(relative risk of liver cancer for those with cirrhosis =
10.2, 95% CI = 3.1-33.9). Incident liver disease and
chronic HBV and HCV were diagnosed in 0.9, 1.8, and
4.7 per 100 person-years. HBV and HCV screening
increased from fewer than 20% to over 60% during this
period of observation (p<.001). Deaths occurred in 57%
of those diagnosed with liver disease relative to 15%
overall (p<.001). Overall, 10% of deaths occurred among
individuals with a diagnosis of liver disease.
Conclusions
Despite care guidelines promoting screening for HBV and
HCV, screening was not universally conducted or, if con-
ducted, not documented. Due to elevated risks of liver
cancer and other liver diseases, HCV and HBV screening
and treatment of viral hepatitis among HIV-infected indi-
viduals should be a priority in the HAART era.
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